Geneos Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GNOS-PV02 / Geneos Therap
GT-30, NCT04251117: GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects with Advanced HCC

Active, not recruiting
1/2
36
US, RoW
GNOS-PV02, INO-9012, Pembrolizumab, CELLECTRA®2000 EP Device
Geneos Therapeutics
HCC
11/24
11/28
GNOS-PV01 / Geneos Therap
NCT04015700: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Active, not recruiting
1
9
US
Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics, GNOS-PV01, Vaccine, CELLECTRA®2000 EP Device supplied by Geneos Therapeutics, Plasmid encoded IL-12, INO-9012
Washington University School of Medicine, Geneos Therapeutics, The Foundation for Barnes-Jewish Hospital
Glioblastoma
05/22
12/25
GEN-PV-001 / Geneos Therap
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GNOS-PV02 / Geneos Therap
GT-30, NCT04251117: GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects with Advanced HCC

Active, not recruiting
1/2
36
US, RoW
GNOS-PV02, INO-9012, Pembrolizumab, CELLECTRA®2000 EP Device
Geneos Therapeutics
HCC
11/24
11/28
GNOS-PV01 / Geneos Therap
NCT04015700: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Active, not recruiting
1
9
US
Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics, GNOS-PV01, Vaccine, CELLECTRA®2000 EP Device supplied by Geneos Therapeutics, Plasmid encoded IL-12, INO-9012
Washington University School of Medicine, Geneos Therapeutics, The Foundation for Barnes-Jewish Hospital
Glioblastoma
05/22
12/25
GEN-PV-001 / Geneos Therap
No trials found

Download Options